Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Jazz Pharmaceuticals (JAZZ) Reports In-Line Q2 EPS, Reaffirms FY Guidance
August 5, 2015 4:30 PM EDTJazz Pharmaceuticals (NASDAQ: JAZZ) reported Q2 EPS of $2.41, in-line with the analyst estimate of $2.41. Revenue for the quarter came in at $333.7 million versus the consensus estimate of $335.86 million.
Jazz Pharmaceuticals sees FY2015 EPS of $9.45-$9.75, versus the consensus of $9.67. Jazz Pharmaceuticals sees FY2015... More
